首页> 美国卫生研究院文献>BMC Biotechnology >An in vitro synthetic biosystem based on acetate for production of phloroglucinol
【2h】

An in vitro synthetic biosystem based on acetate for production of phloroglucinol

机译:基于醋酸盐的间苯三酚生产体外合成生物系统

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPhloroglucinol is an important chemical, and the biosynthesis processes which can convert glucose to phloroglucinol have been established. However, due to approximate 80% of the glucose being transformed into undesirable by-products and biomass, this biosynthesis process only shows a low yield with the highest value of about 0.20 g/g. The industrial applications are usually hindered by the low current productivity and yield and also by the high costs. Generally, several different aspects limit the development of phloroglucinol biosynthesis. The yield of phloroglucinol is one of the most important parameters for its bioconversion especially from economic and ecological points of view. The in vitro biosynthesis of bio-based chemicals, is a flexible alternative with potentially high-yield to in vivo biosynthetic technology.
机译:背景技术间苯三酚是一种重要的化学物质,已经建立了可以将葡萄糖转化为间苯三酚的生物合成方法。但是,由于大约80%的葡萄糖被转化为不良的副产物和生物质,因此这种生物合成过程仅显示出较低的产量,最高值为约0.20 g / g。低电流生产率和良率以及高成本通常阻碍了工业应用。通常,几个不同方面限制间苯三酚生物合成的发展。间苯三酚的产量是其生物转化的最重要参数之一,特别是从经济和生态角度来看。生物基化学物质的体外生物合成是一种灵活的替代方法,具有潜在的高产率,可以替代体内生物合成技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号